论文部分内容阅读
目的探讨酚妥拉明联合垂体后叶素治疗支气管扩张大咯血的临床疗效。方法将我院2008年11月至2011年11月收治的90例支气管扩张大咯血患者随机分为治疗组和对照组各45例,对照组在常规治疗的基础上给予垂体后叶素治疗,治疗组在对照组治疗的基础上加用酚妥拉明,两组疗程均为3～5d。结果治疗组的总有效率为93.3%,对照组的总有效率为75.6%,两组相比较差异有统计学意义(P<0.05)。结论酚妥拉明联合垂体后叶素治疗支气管扩张大咯血的疗效确切,且不良反应少,值得临床借鉴。
Objective To investigate the clinical efficacy of phentolamine combined with pituitrin in the treatment of bronchiectasis and hemoptysis. Methods Ninety patients with bronchiectasis and hemoptysis treated in our hospital from November 2008 to November 2011 were randomly divided into treatment group (45 cases) and control group (45 cases). The control group was given pituitrin on the basis of routine treatment, and the treatment Group in the control group based on the treatment with phentolamine, both treatment courses were 3 ~ 5d. Results The total effective rate of the treatment group was 93.3%, while the total effective rate of the control group was 75.6%. There was significant difference between the two groups (P <0.05). Conclusion Phentolamine combined with pituitary vasopressin treatment of bronchiectasis massive hemoptysis is effective and less adverse reactions, it is worth learning from.